CHO-K1 cells expressing hKv3.1 were characterized in terms of their pharmacological and biophysical properties using whole-cell patch clamp techniques and IonWorks™ HT. Using whole-cell patch clamp techniques the peak I/V relationship was linear and had a high threshold for current activation (-20 mV), typical of hKv3.1 currents. Riluzole and TEA have been shown to block hKv3.1 currents in the micromolar range. For example, application of TEA (200 µM) or riluzole (300 µM) blocked currents within a similar concentration range; 39.6 ± 3.1 % inhibition (peak current, n=5) and 39.9 ± 6.0 % inhibition (end current, n=5) respectively. Functional channel expression over time was monitored using IonWorksTM HT. Channel expression is robust over at least 31 passages. The mean peak hKv3.1 outward current amplitude on stepping to +30 mV from a holding potential of -80 mV was consistently between 3–4 nA. Furthermore, of the cells that sealed, the percent of cells expressing hKv3.1 currents (i.e. currents >500 pA) was consistently between 98–100 %.